If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
Access Campaigner Felipe Carvalho sets out what needs to happen so that everyone in need has access to new COVID-19 treatment - no patents, no monopolies and accountability on public funding for medical research. No one left behind!